SCHEMBL22869928

SCHEMBL22869928

OC1CC2COCC2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22869911 1.00
SCHEMBL28666747 1.00
SCHEMBL22870046 1.00
SCHEMBL14157194 0.82
SCHEMBL13763272 0.81
SCHEMBL19456295 0.81
SCHEMBL2118139 0.81
SCHEMBL14932881 0.81
SCHEMBL28136519 0.79 THRB (0.35)
SCHEMBL2072178 0.76 CYP2C9 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115232057-A Synthesis method of gliclazide intermediate 3-azabicyclo [3.3.0] octane 上海巽田科技股份有限公司 2022-10-25 CN claimed
CN-115232057-A Synthesis method of gliclazide intermediate 3-azabicyclo [3.3.0] octane 上海巽田科技股份有限公司 2022-10-25 CN disclosed
WO-2021000242-A1 THIENOPYRIMIDINE DERIVATIVES HAVING STEREO CONFIGURATIONS AND USE THEREOF IN MEDICINE 广东东阳光药业有限公司 2021-01-07 WO disclosed